Drug intelligence / Profile preview

Macprot

Development stage: Unknown
Lead developer: Macleods Pharmaceuticals
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Oral

Overview

Macprot is a comprehensive nutritional supplement powder developed by Macleods Pharmaceuticals. It is formulated with a diverse blend of active ingredients, including bovine colostrum, docosahexaenoic acid (DHA), gamma-linolenic acid (GLA), inositol, and taurine, alongside a full spectrum of essential vitamins (A, B-complex, C, D, E, K) and minerals (calcium, phosphorus, magnesium, iron, zinc, copper, manganese, iodine, chromium, molybdenum, and selenium). Administered orally, Macprot is designed to address nutritional deficiencies and support overall health by promoting immune function, bone health, and muscle growth and recovery. It is typically available in various flavors such as vanilla, chocolate, and kesar.

Brand names: Macprot

Beyond the preview

Go deeper on Macprot.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macprot.

Explore the full profile